The table below shows Guardant Health, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$184.76M
-$239.86M
-$324.98M
-$309.46M
-$209.02M
-$103.93M
Capital expenditure
$48.31M
$35.09M
$20.49M
$77.46M
$75.03M
$36.17M
Investing cash flow
-$627.20M
-$261.31M
$840.25M
$149.82M
-$63.16M
-$617.09M
Dividends paid
-
-
-
-
GH operating cash flow (10-K history)
Guardant Health, Inc. reported operating cash flow of -$184.76M for fiscal year 2025. That is up 23.0% from -$239.86M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$36.71M (FY 2016) to -$184.76M. Figures come from the company's audited annual reports as filed with the SEC.
